Understanding health outcomes in drug users at high risk for HIV
The Epidemiology of the Weiss Cohort Project
This study is looking at the long-term health effects of drug use on people at high risk for HIV, especially focusing on how it affects their overall health and cancer rates over 35 years, to help improve care for this group.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10654696 on NIH RePORTER |
What this research studies
This research investigates the long-term health outcomes of drug users who are at high risk for HIV, focusing on mortality and cancer epidemiology over a 35-year period. By utilizing a unique cohort of nearly 11,000 diverse drug users, the study aims to analyze vital statistics and cancer data to identify patterns and risks associated with HIV and drug use. The research will help inform clinical practices and health system planning to better address the needs of this population. Participants will be followed up indefinitely, allowing for comprehensive data collection and analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research include drug users, both HIV-positive and HIV-negative, who have a history of substance use and are part of a diverse demographic.
Not a fit: Patients who do not have a history of drug use or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and targeted interventions for drug users at high risk for HIV.
How similar studies have performed: Previous research has shown success in understanding health outcomes in similar cohorts, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Weiss, Stanley H — Rutgers Biomedical and Health Sciences
- Study coordinator: Weiss, Stanley H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.